Arcam press archives

Please note that most press releases prior to June 2013 are available in Swedish only. From June 2013, all releases and quarterly reports are published in both Swedish and English.

Magnus René, CEO and Johan Brandt, CFO leave Arcam

Magnus René, President and CEO of Arcam AB (publ) (“Arcam” or the “Company”), and Johan Brandt, CFO and deputy CEO of the Company have both chosen to terminate their respective employment agreements with the Company. Magnus René has been CEO of Arcam since 2001 and Johan Brandt has been CFO of the Company since 2012. Magnus René has a notice period of 6 months and will remain in his position until a new CEO is appointed or at the latest until June 3, 2018. Johan Brandt has a notice period of 3 months and will remain in his position until a new CFO is appointed or at the latest until April 30, 2018. 

Go to article

Arcam evaluates strategic alternatives for DTI

The Board of Directors of Arcam AB (publ) ("Arcam" or the "Company") has resolved to initiate a process to explore and evaluate strategic alternatives regarding DiSanto Technology Inc. (“DTI”), to strengthen its focus and capabilities within both Additive Manufacturing and conventional manufacturing. As part of this process, the Company intends to consider a range of strategic and structural options, which may include, among other things, a restructuring, full or partial separation of DTI via a spin-off, sale, joint venture, strategic collaboration or other transaction. 

Go to article

Arcam announces outcome of rights issue

The result of Arcam Aktiebolag's (publ) (“Arcam” or the “Company”) rights issue, for which the subscription period ended on November 9, 2017, indicates that 4,034,116 ordinary shares, corresponding to 98.2 percent of the offered ordinary shares, were subscribed for by exercise of subscription rights. Additionally, applications for subscription without subscription rights of 1,541,367 ordinary shares, corresponding to approximately 37.5 percent of the offered ordinary shares, have been received. Accordingly, the rights issue is fully subscribed. Through the rights issue, Arcam will receive proceeds amounting to approximately MSEK 986 before issue costs.

Go to article

Arcam news at Formnext 2017

Arcam AB, supplier of Additive Manufacturing ("AM") equipment and part of GE Additive, participates at Formnext with AM systems through Arcam EBM, metal powders through AP&C and orthopedic contract manufacturing through DTI. Arcam, GE Additive and Concept Laser will exhibit together at Formnext displaying their broad combined offerings to the market. 

Go to article

Arcam announces prospectus in connection with preferential rights issue

Arcam AB (publ) ("Arcam" or the "Company") announced, on the 10 October 2017, that the Board of Directors resolved to launch a preferential rights issue of 4,109,286 ordinary shares with preferential rights for the Company's existing shareholders (the "Rights Issue"), with the support from the approval by the Annual General Meeting 16 June 2017. Accordingly, Arcam's Board of Directors have prepared a prospectus, which today has been approved and registered by the Swedish Financial Supervisory Authority ("SFSA").

Go to article

Arcam resolves on a preferential rights issue of approximately MSEK 986

The Board of Directors of Arcam Aktiebolag (publ) (“Arcam” or the “Company”) has, pursuant to the authorization granted by the annual general meeting on 16 June 2017, resolved on a new share issue of a maximum of 4,109,286 ordinary shares with preferential right for the Company’s existing shareholders (the “Rights Issue”). If the Rights Issue is fully subscribed, the Company will be provided with approximately MSEK 986 before deduction of transaction costs. The subscription price in the Rights Issue is SEK 240 per ordinary share.

Go to article

AP&C receives ISO13485 certification

Arcam AB, listed on NASDAQ Stockholm, and a leading supplier in the Additive Manufacturing (“AM”) field, announces that its powder manufacturing subsidiary AP&C in Quebec, Canada, received ISO13485 certification. The ISO13485 is particularly designated for the orthopedic implant industry. In addition to the new ISO13485 certification, AP&C is already certified to ISO9001 and AS9100.

Go to article

AP&C unveils new state-of-the-art powder manufacturing facility in Quebec, Canada

Arcam AB, listed on NASDAQ Stockholm, and a leading supplier in the Additive Manufacturing (“AM”) field, announces that its powder manufacturing subsidiary AP&C in Quebec, Canada, today officially inaugurated its new cutting-edge facility in Saint-Eustache. The manufacturing plant will welcome 106 new employees by the end of the year, making it one of the largest employers in the region and marking a significant growth for AP&C, which has quadrupled in size over the last two years.

Go to article

GE orders 10 EBM systems

Arcam AB, listed on NASDAQ Stockholm, has received an order from GE on 10 EBM systems. GE, which is the company's main owner since November 2016, will use the systems in different companies in the GE Group. The systems will be delivered in 2017 and 2018. The order value is about 100 MSEK.

Go to article


RSS for: Press releases

Next page